Patients undergoing major surgery or sustaining severe trauma are at risk of developing morbidity and mortality from postoperative or posttraumatic systemic inflammatory response syndrome (SIRS), sepsis and multiple organ failure (MOF).
In particular, patients with scores ≥5 had high probability of developing morbidity events in ICU.
Mice were monitored daily and electively euthanized by CO2 asphyxia when any mouse developed morbidity.
Mice were electively euthanized by CO2 asphyxia when any mouse developed morbidity.
Likewise, none of the mice treated with CD19L sTRAIL alone developed morbidity due to treatment toxicity or overt leukemia.
Afterwards, nearly half of the DO mice developed morbidity requiring euthanasia before 35 days, resulting in significantly reduced survival compared to the founder C57BL/6J strain (Fig. 1A).
It showed its capacity to identify a minimum core of predictors generally recognized as essential to pragmatically evaluate the risk of developing morbidity after heart surgery.
Nearly half of the DO mouse population rapidly developed morbidity associated with necrosis of lung tissue and granulomas, with neutrophil influx.
A long term surveillance programme must therefore be accessible to all patients, should identify those at risk of developing morbidity and target the interventions at the high risk population of patients.
